Herrmann D B, Herz R, Fröhlich J
Eur J Clin Invest. 1985 Aug;15(4):221-6. doi: 10.1111/j.1365-2362.1985.tb00172.x.
Net acetate uptake/release by various tissues was studied in vivo in fed, starved and Paromomycin-treated rats and in patients with cirrhosis of the liver. In humans the portal vein, hepatic vein and hepatic arterial blood flow rates were determined simultaneously. In rats acetate is only intestinally produced and released into the portal vein. Intestinal production is decreased by 33% in starved and Paromomycin-treated rats compared to fed animals. Portal vein hepatic vein acetate differences are linearly related to the portal vein acetate concentration (r = 0.92). Acetate uptake from the portal vein by the liver was found when the portal venous concentration exceeded 180 mumol l-1. In humans the hepatic net acetate uptake from the portal vein/net acetate release into the hepatic vein, measured as mmol min-1, is linearly related to the portal vein acetate concentration (r = 0.96). The data indicate that the liver may homeostatically regulate the systemic acetate concentration in rat and man.
在喂食、饥饿和用巴龙霉素处理的大鼠以及肝硬化患者体内研究了各种组织对乙酸盐的净摄取/释放情况。在人体中,同时测定了门静脉、肝静脉和肝动脉的血流速率。在大鼠中,乙酸盐仅在肠道产生并释放到门静脉中。与喂食的动物相比,饥饿和用巴龙霉素处理的大鼠的肠道乙酸盐产生量减少了33%。门静脉与肝静脉之间的乙酸盐差异与门静脉乙酸盐浓度呈线性相关(r = 0.92)。当门静脉浓度超过180μmol l-1时,发现肝脏从门静脉摄取乙酸盐。在人体中,以mmol min-1为单位测量的肝脏从门静脉的乙酸盐净摄取/释放到肝静脉的乙酸盐净释放量与门静脉乙酸盐浓度呈线性相关(r = 0.96)。数据表明,肝脏可能通过稳态调节大鼠和人体中的全身乙酸盐浓度。